Russell Investments Group’s Anika Therapeutics ANIK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.62K Buy
531
+95
+22% +$1.01K ﹤0.01% 3426
2025
Q1
$6.55K Buy
436
+165
+61% +$2.48K ﹤0.01% 3302
2024
Q4
$4.46K Buy
271
+102
+60% +$1.68K ﹤0.01% 3309
2024
Q3
$4.17K Buy
169
+98
+138% +$2.42K ﹤0.01% 3259
2024
Q2
$1.8K Buy
71
+25
+54% +$633 ﹤0.01% 3367
2024
Q1
$1.17K Buy
46
+12
+35% +$305 ﹤0.01% 3122
2023
Q4
$770 Buy
+34
New +$770 ﹤0.01% 3087
2023
Q3
Sell
-602
Closed -$15.6K 3520
2023
Q2
$15.6K Sell
602
-54
-8% -$1.4K ﹤0.01% 2885
2023
Q1
$18.8K Sell
656
-86,222
-99% -$2.48M ﹤0.01% 2821
2022
Q4
$2.57M Sell
86,878
-10,463
-11% -$310K 0.01% 1430
2022
Q3
$2.32M Sell
97,341
-7,500
-7% -$178K 0.01% 1465
2022
Q2
$2.34M Buy
104,841
+3,200
+3% +$71.4K ﹤0.01% 1507
2022
Q1
$2.55M Sell
101,641
-5,823
-5% -$146K ﹤0.01% 1511
2021
Q4
$3.85M Sell
107,464
-10,932
-9% -$391K 0.01% 1416
2021
Q3
$5.04M Sell
118,396
-22,445
-16% -$955K 0.01% 1248
2021
Q2
$6.1M Sell
140,841
-112,348
-44% -$4.86M 0.01% 1219
2021
Q1
$10.3M Buy
253,189
+46,728
+23% +$1.91M 0.02% 921
2020
Q4
$9.34M Buy
206,461
+66,236
+47% +$3M 0.02% 897
2020
Q3
$4.96M Buy
140,225
+31,627
+29% +$1.12M 0.01% 1131
2020
Q2
$3.99M Buy
108,598
+49,844
+85% +$1.83M 0.01% 1234
2020
Q1
$1.68M Buy
58,754
+6,469
+12% +$185K ﹤0.01% 1558
2019
Q4
$2.72M Buy
52,285
+17,042
+48% +$887K 0.01% 1567
2019
Q3
$1.93M Buy
35,243
+9,239
+36% +$505K ﹤0.01% 1698
2019
Q2
$1.05M Sell
26,004
-8,892
-25% -$359K ﹤0.01% 1965
2019
Q1
$1.06M Buy
34,896
+6,169
+21% +$187K ﹤0.01% 2038
2018
Q4
$966K Sell
28,727
-26,743
-48% -$899K ﹤0.01% 1984
2018
Q3
$2.34M Buy
55,470
+15,853
+40% +$669K ﹤0.01% 1679
2018
Q2
$1.27M Sell
39,617
-5,941
-13% -$190K ﹤0.01% 1993
2018
Q1
$2.27M Sell
45,558
-7,847
-15% -$390K ﹤0.01% 1766
2017
Q4
$2.85M Buy
53,405
+9,545
+22% +$510K ﹤0.01% 1649
2017
Q3
$2.54M Sell
43,860
-6,647
-13% -$386K ﹤0.01% 1647
2017
Q2
$2.49M Sell
50,507
-12,100
-19% -$597K ﹤0.01% 1607
2017
Q1
$2.72M Sell
62,607
-49,873
-44% -$2.17M 0.01% 1581
2016
Q4
$5.53M Buy
+112,480
New +$5.53M 0.01% 1178